Patient Access: Early Access, Compassionate Use, Off-label Use
06.03.2020 11:59
This seminar provides information on early access programmes, HTA requirements, CUP and off-label use in Europe
Termindetails
Wann
30.06.2020
von 09:00 bis 17:00
von 09:00 bis 17:00
Wo
Frankfurt
Kontakttelefon
+49 6221 500-680
Teilnehmer
This seminar is intended for workers in the healthcare industry responsible for market access, healthcare management and, in particular, patient access programmes.
Seminar goal:
This seminar addresses the various options for fast access to innovative medicines in Europe, the reimbursement options and the mechanisms of compounding and off-label use.
Topics:
- Patient access to orphan drugs and high-price therapies
- Early access schemes in Europe: Are they reimbursed?
- Pricing considerations
- Compassionate use programmes in Europe
- Compounding, off-label use and hospital exemption
